Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Economic Times
The Economic Times

Government okays Skymap Pharmaceuticals' Rs 121-cr bid to buy IMPCL

New Delhi: The government has approved strategic sale of Indian Medicines Pharmaceutical Corporation Ltd (IMPCL) to Skymap Pharmaceuticals Pvt Ltd for over Rs 121 crore, the finance ministry said on Tuesday.

The government had received two financial bids for buying 100 per cent stake, along with management control, in IMPCL, and among them, M/s. Skymap Pharmaceuticals Pvt Ltd has emerged as the highest bidder at Rs 121,00,94,400, which was also above the reserve price, the ministry said in a statement.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.